Pick up a tin of vanaspati from any Indian kirana store and read the label. Not the front - the back. Past the brand name, past the "vegetable ghee" description, past the cooking image and the promise of pure taste. Find the ingredients list and the nutritional information panel. What you will find, if the label is honest, is this: partially hydrogenated vegetable fat. And in the nutritional panel, under fats: trans fatty acids.
Most people who have cooked with vanaspati for years - or whose families have - have never read this. They were told it was vegetable ghee. They were shown an image of a cow on the label. The tin was familiar, the price was manageable, and no one explained in clear terms what partial hydrogenation means or what trans fats do inside the human body.
This article explains both. Clearly, with the evidence, and without unnecessary alarm - because the facts about industrial trans fats are alarming enough without embellishment. By the end, you will understand precisely why vanaspati and pure desi ghee are not comparable products, not interchangeable fats, and not remotely equivalent in their long-term health consequences. One is a food that has nourished Indian families for thousands of years. The other is an industrial product invented in the twentieth century whose principal active compounds have been identified as among the most harmful dietary substances in modern nutritional science.
What Vanaspati Actually Is - and How It Is Made
Vanaspati is not a dairy product. It has never contained a single drop of cow's milk. The word "vegetable ghee" printed on its label is a marketing description of texture and appearance - it looks and melts somewhat like ghee - not a description of its origin, composition, or nutritional properties.
The Origin: A Colonial-Era Industrial Invention
Vanaspati was introduced to India by the Dutch company Hindustan Lever (now Hindustan Unilever) in 1930, under the brand name Dalda - a name that became so synonymous with the product that vanaspati is still colloquially called "dalda" across North India decades after other brands entered the market. It was positioned from its introduction as a cheap alternative to desi ghee for households that could not afford traditional clarified butter - a market created by the economics of the colonial period, when traditional ghee production was expensive and dairy access was limited for lower-income populations.
The product was not designed with nutritional equivalence in mind. It was designed for price accessibility and shelf stability. The technology that achieved both of these goals - partial hydrogenation of vegetable oils - was understood even at the time of vanaspati's introduction to produce a chemically modified fat with properties fundamentally different from both the natural vegetable oils it was made from and the dairy fat it was positioned to replace.
The Process: What Partial Hydrogenation Does to Vegetable Oil
To understand why vanaspati is harmful, you must understand what partial hydrogenation does at the molecular level - because the harm is chemical and specific, not vague or theoretical.
Natural vegetable oils - sunflower, groundnut, palm, soybean - are predominantly liquid at room temperature because their fatty acids contain double bonds between carbon atoms. These double bonds keep the molecular chain kinked, preventing the tight packing that produces solid fat. In their natural state, these double bonds are in the cis configuration - both hydrogen atoms are on the same side of the double bond, producing the natural kink.
Partial hydrogenation is an industrial process in which hydrogen gas is bubbled through liquid vegetable oil in the presence of a nickel catalyst at high temperature and pressure. The hydrogen atoms react with the double bonds in the fatty acid chains, progressively saturating them and converting the liquid oil into a semi-solid or solid fat. This is how the spreadable, lard-like consistency of vanaspati is achieved from liquid vegetable oil.
The problem - and it is a severe one - is that partial hydrogenation does not simply add hydrogen atoms to double bonds. It also, as a chemical side effect of the reaction conditions, converts a significant proportion of the remaining cis double bonds into trans double bonds. In a trans double bond, the hydrogen atoms are on opposite sides of the molecule, which straightens the fatty acid chain and produces a fat with properties dramatically different from either the original cis unsaturated fat or a naturally saturated fat.
These geometrically altered fatty acids are called industrial trans fatty acids - and they are not found in nature in meaningful quantities. Small amounts of naturally occurring trans fats exist in ruminant dairy fat (vaccenic acid, conjugated linoleic acid) and have neutral to beneficial health effects. Industrial trans fats from partial hydrogenation are a completely different category - same geometric name, profoundly different biochemical behaviour and health consequences.
What Industrial Trans Fats Do to the Human Body
The scientific evidence on industrial trans fatty acids is among the most consistent and most damning in all of nutritional epidemiology. This is not a contested area of nutrition science. The harmful effects of industrial trans fats have been established beyond reasonable doubt in thousands of studies across multiple decades.
The Lipid Profile Effect: The Worst Possible Change
Dietary fat's effect on blood lipids is typically framed as a trade-off: saturated fat raises LDL but also raises HDL; polyunsaturated fat lowers LDL but may also lower HDL; the net cardiovascular effect depends on which change dominates. Industrial trans fats bypass this trade-off entirely by doing both the worst things simultaneously:
Industrial trans fats raise LDL cholesterol - the form of cholesterol associated with arterial plaque formation - by approximately the same magnitude as saturated fat at equivalent intake.
Industrial trans fats lower HDL cholesterol - the protective form that performs reverse cholesterol transport, removing excess cholesterol from arterial walls - an effect that naturally occurring saturated fats do not produce.
The combined result is the worst possible lipid profile change: LDL rises, HDL falls, and the LDL:HDL ratio - the most clinically predictive cardiovascular risk marker - deteriorates more severely per gram of industrial trans fat consumed than from any other dietary fat category. A landmark analysis published in the New England Journal of Medicine found that replacing 2 percent of energy intake from trans fats with unsaturated fats would reduce cardiovascular disease risk by 53 percent - a larger effect size than almost any other single dietary intervention in cardiovascular research.
The Inflammatory Effect: Beyond Lipid Profiles
Industrial trans fats also directly promote systemic inflammation through mechanisms independent of their lipid effects. They elevate circulating levels of inflammatory markers including C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-alpha) - the same inflammatory cytokines most consistently associated with cardiovascular disease, type 2 diabetes, and metabolic syndrome. This inflammatory effect means that the cardiovascular harm of industrial trans fats operates through multiple pathways simultaneously - not only through the LDL:HDL deterioration but through direct arterial inflammatory damage as well.
The Endothelial Effect: Direct Arterial Wall Damage
Industrial trans fats impair endothelial function - the ability of the arterial lining to produce nitric oxide and regulate vascular tone. Endothelial dysfunction is the earliest detectable stage of atherosclerosis, preceding lipid plaque formation by years or decades. Research published in the American Journal of Clinical Nutrition found that dietary trans fat intake was directly associated with impaired endothelial-dependent vasodilation - measurable on vascular ultrasound - independently of the lipid profile changes described above. This means industrial trans fats damage the arterial lining directly, not just indirectly through lipid effects.
The Global Regulatory Response
The scientific evidence against industrial trans fats has been so consistent and so severe that it has produced the most extensive global regulatory response of any single dietary compound in history:
The World Health Organisation's REPLACE initiative (2018) set a global target of eliminating industrially produced trans fats from the global food supply by 2023. As of 2026, over 60 countries have implemented mandatory limits or bans.
The United States Food and Drug Administration removed partially hydrogenated oils from its "generally recognised as safe" (GRAS) category in 2015 and mandated their complete elimination from the US food supply by 2018.
India's FSSAI progressively reduced the permissible trans fat limit in edible oils and fats: from 10 percent (pre-2021) to 5 percent (2021) to 2 percent (2022). The 2 percent limit applies to vanaspati and all partially hydrogenated fats. At the time of writing, enforcement of the 2 percent limit in the retail vanaspati market remains inconsistent, and independent testing by consumer organisations has found trans fat levels in some retail vanaspati products exceeding the current regulatory limit.
This regulatory trajectory - driven entirely by the severity and consistency of the scientific evidence - is the clearest possible official confirmation that industrial trans fats are not an acceptable dietary component at any meaningful level of intake. Countries with the most nutritional research resources in the world have concluded that these compounds are sufficiently harmful that they should not be in the food supply at all.
What Vanaspati Is Doing in the Indian Kitchen Right Now
Despite the regulatory pressure and growing consumer awareness, vanaspati remains widely available and widely used in India - particularly in lower-income households, street food preparation, and industrial food manufacturing where cost is the dominant consideration.
The FSSAI survey data indicates that vanaspati continues to be one of the most commonly used cooking fats in North Indian states - Bihar, Uttar Pradesh, Rajasthan, Madhya Pradesh, and Jharkhand - where desi ghee has historically been the aspirational daily fat but where price barriers have made vanaspati the practical substitute for millions of households.
The irony of this substitution is precise and painful. The families who switched from desi ghee to vanaspati to save money are the same families who bear the highest burden of cardiovascular disease, metabolic syndrome, and diabetes in India - conditions for which industrial trans fat consumption is now understood to be a significant dietary driver. The economic logic of the substitution is understandable. The nutritional consequence is severe. And the tragedy is that the families who were led to believe they were making a sensible, budget-conscious dietary choice were never given the information that would have allowed them to make a genuinely informed decision.
How Vanaspati Gets Away With Being Called "Ghee"
The labelling practices around vanaspati in India deserve specific attention - because the way these products are marketed continues to create confusion in households where nutritional label literacy is low.
The term "vegetable ghee" is permitted on vanaspati packaging under Indian food law, provided it appears alongside the required declaration "partially hydrogenated vegetable fat" and the mandatory trans fat disclosure in the nutritional panel. The problem is that the front-of-pack visual and naming - "vegetable ghee," often with pastoral imagery - overwhelmingly dominates the consumer perception, while the trans fat disclosure, placed in small print on the nutritional panel, is read by a fraction of purchasers.
The FSSAI requires that the declaration "CONTAINS TRANS FATS - NOT SUITABLE FOR PEOPLE WITH HEART DISEASE, HIGH CHOLESTEROL, DIABETES AND PREGNANT WOMEN" appear on vanaspati packaging - but the size, placement, and visibility of this warning varies considerably across products, and its enforcement in retail environments is imperfect.
For any consumer in any Indian household: if the label says "partially hydrogenated" anywhere in the ingredients, the product contains industrial trans fats. The form it takes - whether vanaspati tin, baked good, fried snack, or restaurant preparation - does not change this. Partial hydrogenation is the marker. Find it and know what it means.
Pure Desi Ghee: What Vanaspati Was Pretending to Be
The distance between vanaspati and genuine desi ghee is not a matter of quality difference within the same product category. They are not premium versus budget versions of the same thing. They are products with opposite nutritional profiles - one delivering industrial trans fats that raise LDL, lower HDL, inflame arteries, and impair endothelial function; the other delivering butyric acid for gut healing, CLA for cardiovascular protection, Vitamin K2 for arterial health, Vitamin D for bone density, and fat-soluble vitamins for immune function.
The comparison is not between two fats. It is between a food and its industrial counterfeit.
Genuine A2 bilona desi ghee - made from the curd of indigenous cow milk through the traditional fermentation and churning process - is a whole food whose composition has been understood and deliberately maintained across thousands of years of Indian culinary and Ayurvedic tradition. The Charaka Samhita does not mention vanaspati. It could not have - vanaspati did not exist until 1930. What it does say, in its extensive documentation of ghee's therapeutic properties, is that ghee from indigenous cows through the curd-based bilona method is one of the most nutritionally complete and therapeutically valuable fats available to the human body.
Vanaspati was invented to fill the economic gap between what genuine ghee costs and what lower-income households can pay. It filled that gap with an industrial product whose principal active compounds are now banned or strictly limited by food safety authorities in most developed nations. The families who adopted it were not served well.
The Comparison That Should End the Debate
|
Factor |
Vanaspati (Dalda / Vegetable Ghee) |
Pure A2 Bilona Desi Ghee |
|
Origin |
Partially hydrogenated vegetable oil |
Curd from indigenous A2 cow milk |
|
Year introduced to India |
1930 - colonial-era industrial product |
Thousands of years - Vedic tradition |
|
Primary harmful compound |
Industrial trans fatty acids |
None - no harmful compounds |
|
Effect on LDL cholesterol |
Raises LDL significantly |
Neutral to beneficial (stearic acid) |
|
Effect on HDL cholesterol |
Lowers HDL - uniquely harmful |
Neutral to beneficial (CLA) |
|
Endothelial function |
Directly impairs arterial lining |
Neutral to positive (butyrate reduces inflammation) |
|
Systemic inflammation |
Raises CRP, IL-6, TNF-alpha |
Reduces NF-κB through butyrate |
|
Butyric acid |
None |
Present - elevated by fermentation |
|
CLA |
None |
Present - cardioprotective |
|
Vitamin K2 |
None |
Present - arterial calcification inhibitor |
|
Vitamin D |
None |
Present - bone and immune function |
|
Vitamin A (beta-carotene) |
None |
Present - deep golden colour from pasture grazing |
|
Vitamin E |
None |
Present - membrane antioxidant |
|
FSSAI regulatory status |
Permitted with 2% trans fat limit; warning label required |
Regulated as pure dairy fat - no trans fat concerns |
|
WHO position |
Target for global elimination (REPLACE initiative) |
No restriction - traditional whole food |
|
Banned or restricted in |
United States, European Union, Canada, and 60+ countries |
Not restricted in any country |
|
Cardiovascular effect |
Among the most harmful dietary fats identified |
Beneficial when used in moderation |
|
Appropriate for heart patients |
Explicitly contra-indicated - FSSAI warning required |
Appropriate in moderation - consult physician |
|
Appropriate for pregnant women |
Explicitly contra-indicated - FSSAI warning required |
Appropriate - traditionally prescribed postpartum |
|
Traditional Ayurvedic status |
Does not exist in Ayurvedic tradition |
Supreme oleating substance - Charaka Samhita |
|
Price per 500g (approx.) |
₹120–₹180 |
₹1,350 (A2 bilona) |
If Price Is the Barrier - Here Is the Honest Calculation
The price difference between vanaspati and genuine A2 bilona ghee is real and significant. At ₹120 to ₹180 versus ₹1,350 for 500 grams, the cost difference is approximately tenfold. For households where this difference is genuinely prohibitive, the honest calculation is not "choose between them" - it is "choose the smaller amount of the right thing over a larger amount of the wrong thing."
One teaspoon of A2 bilona ghee per day - the therapeutic minimum that delivers meaningful butyrate, CLA, and fat-soluble vitamins - costs approximately ₹27 per day. A 500g jar provides approximately 50 days of daily use at this quantity. Against the cardiovascular, metabolic, and inflammatory cost of equivalent daily consumption of industrial trans fats, the economic comparison looks quite different.
Vanaspati is not cheap. It is cheap to buy and expensive to live with.
The families who switched from desi ghee to vanaspati a generation ago were given no honest account of what they were trading. This article is a partial correction of that account. The information exists. The regulatory bodies have acted on it. The WHO has named industrial trans fat elimination as one of its highest global health priorities.
What remains is for every Indian household that currently uses vanaspati to read its label, understand what "partially hydrogenated" means, and make a genuinely informed choice about what belongs in their kitchen.
Our Pure A2 Gir Cow Desi Ghee - Bilona Method is made from Gir cow milk through the complete traditional bilona process - fermented, churned, slowly clarified. No partial hydrogenation. No trans fats. No hexane. No bleaching. No deodorisation. No industrial chemistry of any kind. The ingredients are: whole A2 cow milk, lactic acid bacterial culture, time, and heat. That is all.
It costs more than vanaspati because it is a fundamentally different product made through a fundamentally different process from a fundamentally different source. It is not competing with vanaspati in any meaningful sense. It is not a premium version of the same thing. It is what vanaspati was pretending to be.
Educational Note: This article provides nutritional information for educational purposes. Claims about industrial trans fats and cardiovascular disease are supported by extensive peer-reviewed research and regulatory actions by WHO, FDA, FSSAI, and health authorities in over 60 countries. This article does not constitute medical advice. Individuals with diagnosed cardiovascular disease, diabetes, or other health conditions should consult their physician regarding dietary choices.

